Chloe Orkin

University Name

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Virology

90%

Pharmacotherapy

70%

Hiv

90%

Antiviral Therapy

80%

Drug Repurposing

30%

Infectious Disease

30%

Hiv/aids Research

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Clinical Research Facility

Open Date: 2023-09-01

Close Date:

Grant: Close

Investigating the Impact of Monkey Pox virus in People living with HIV

Open Date: 2022-09-01

Close Date: 2023-08-01

Grant: Close

The ILANA Study: Implementation of Cabotegravir + Rilpivirine Long-Acting in the UK

Open Date: 2022-04-01

Close Date: 2024-03-01

Grant: Close

Sexual Health & HIV All East Research Centre

Open Date: 2021-01-01

Close Date: 2025-09-01

Grant: Close

The IDEAL Study: Investigating The DEterminants Of COVID-19 Outcomes Across East London

Open Date: 2021-01-01

Close Date:

Articles21

Staff disability data in UK higher education: Evidence from EDI reports

Article Link

Year:

2024

Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England

Article Link

Year:

2024

Ageism: the -ism affecting the lives of older people living with HIV

Article Link

Year:

2024

Cross-sectional survey of sexual health professionals' experiences and perceptions of the 2022 mpox outbreak in the UK

Article Link

Year:

2024

Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)

Article Link

Year:

2024

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Article Link

Year:

2024

Should Human Immunodeficiency Virus Testing Be Replaced With Combined Blood-Borne Virus Testing?

Article Link

Year:

2024

Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis

Article Link

Year:

2024

Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial

Article Link

Year:

2024

SHARING to create knowledge in a crisis

Article Link

Year:

2023

Public understanding and awareness of and response to monkeypox virus outbreak: A cross‐sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency

Article Link

Year:

2023

Experiences of initiating rapid antiretroviral therapy among people newly diagnosed with HIV in East London: a qualitative study

Article Link

Year:

2023

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.

Article Link

Year:

2023

Hepatitis delta infection among persons living with HIV in Europe

Article Link

Year:

2023

Mpox in people with advanced HIV infection: a global case series.

Article Link

Year:

2023

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

Article Link

Year:

2023

Reflections and intersections: disability, ‘ableism’ and metamodern leadership

Article Link

Year:

2023

Estimating the global impact of coronavirus disease 2019 on people living with HIV

Article Link

Year:

2023

Lenacapavir in first-line therapy

Article Link

Year:

2023

Monkeypox

Article Link

Year:

2023

Clinical research in the NHS: a cross-sectional study of research engagement during the monkeypox pandemic

Article Link

Year:

2023

Collaborators11

Julie fox

University College London

UNITED KINGDOM

Félix Gutiérrez

Professor of Medicine

Universidad Miguel Hernández de Elche

SPAIN

Romain Palich

Sorbonne Université

FRANCE

Sara Paparini

Senior Lecturer in Applied Health Research

Queen Mary University of London

UNITED KINGDOM

Katharina Kusejko

University of Zurich

SWITZERLAND

John Thornhill

Imperial College London

UNITED KINGDOM

José Antonio Lepe

SPAIN

Begoῆa Martinez de Tejada

University Hospital of Geneva

SWITZERLAND

Kevin Deane

Open University

UNITED KINGDOM

ESTEBAN MARTINEZ

Senior Consultant & Associate Professor of Medicine

SPAIN

CHRISTINE KATLAMA

FRANCE

How do I reach out?

Meet Kite AI